Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone

  • Bernard Charbonnel
  • , Avraham Karasik
  • , Ji Liu
  • , Mei Wu
  • , Gary Meininger*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

716 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science